Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gurman Kaur

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Brain : a Journal of Neurology|June 27, 2012
Natural killer cells and their receptors in multiple sclerosisGurman Kaur, John Trowsdale, Lars Fugger
Molecular Immunology|August 7, 2010
Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cellsGurman Kaur, Jane C Goodall, Lorna B Jarvis, et al.
Immunology|May 9, 2008
The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cellsJeremy D Isaacs, Oliver A Garden, Gurman Kaur, et al.
Immunology|April 12, 2007
CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cellsRichard C Duggleby, Tovah N F Shaw, Lorna B Jarvis, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2009
A role of cellular prion protein in programming T-cell cytokine responses in diseaseRebecca J Ingram, Jeremy D Isaacs, Gurman Kaur, et al.
Med (New York, N.Y.)|March 22, 2021
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosisMax Kaufmann, Hayley Evans, Anna-Lena Schaupp, et al.
Nature Communications|June 27, 2017
Structural and regulatory diversity shape HLA-C protein expression levelsGurman Kaur, Stephanie Gras, Jesse I Mobbs, et al.
Nature Neuroscience|June 21, 2022
Identification of early neurodegenerative pathways in progressive multiple sclerosisMax Kaufmann, Anna-Lena Schaupp, Rosa Sun, et al.
Nature|July 18, 2012
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam P Gregory, Calliope A Dendrou, Kathrine E Attfield, et al.
Science Translational Medicine|November 4, 2016
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunityCalliope A Dendrou, Adrian Cortes, Lydia Shipman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Brain : a Journal of Neurology|June 27, 2012
Natural killer cells and their receptors in multiple sclerosisGurman Kaur, John Trowsdale, Lars Fugger
Molecular Immunology|August 7, 2010
Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cellsGurman Kaur, Jane C Goodall, Lorna B Jarvis, et al.
Immunology|May 9, 2008
The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cellsJeremy D Isaacs, Oliver A Garden, Gurman Kaur, et al.
Immunology|April 12, 2007
CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cellsRichard C Duggleby, Tovah N F Shaw, Lorna B Jarvis, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2009
A role of cellular prion protein in programming T-cell cytokine responses in diseaseRebecca J Ingram, Jeremy D Isaacs, Gurman Kaur, et al.
Med (New York, N.Y.)|March 22, 2021
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosisMax Kaufmann, Hayley Evans, Anna-Lena Schaupp, et al.
Nature Communications|June 27, 2017
Structural and regulatory diversity shape HLA-C protein expression levelsGurman Kaur, Stephanie Gras, Jesse I Mobbs, et al.
Nature Neuroscience|June 21, 2022
Identification of early neurodegenerative pathways in progressive multiple sclerosisMax Kaufmann, Anna-Lena Schaupp, Rosa Sun, et al.
Nature|July 18, 2012
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam P Gregory, Calliope A Dendrou, Kathrine E Attfield, et al.
Science Translational Medicine|November 4, 2016
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunityCalliope A Dendrou, Adrian Cortes, Lydia Shipman, et al.
Pageof 2